The Clinical Spectrum ofDe NovoDonor-Specific Antibodies in Pediatric Renal Transplant Recipients
about
Application and interpretation of histocompatibility data in pediatric kidney transplantation.Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation.Application of an epitope-based allocation system in pediatric kidney transplantation.Clinically relevant interpretation of solid phase assays for HLA antibody.HLA epitope matching in pediatric renal transplantation.Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.Biomarkers to detect rejection after kidney transplantation.Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.Donor-specific HLA antibodies and graft function in kidney-transplanted children - the Vienna cohort.Minimum mycophenolic acid levels are associated with donor-specific antibody formation.Endothelial activation, lymphangiogenesis, and humoral rejection of kidney transplants.Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information.Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies.The lack of Lazarus effect with proteasome inhibition.Clinical and histopathologic features of antibody-mediated rejection among pediatric renal transplant recipients with preformed vs de novo donor-specific antibodies.Incidence, Characterization and Impact of Newly Detected Donor Specific Anti-HLA Antibody in the First Year after Pediatric Heart Transplantation: A Report From the CTOTC-04 Study.Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation.A Randomized Trial of a Multicomponent Intervention to Promote Medication Adherence: The Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT).
P2860
Q36380010-A05FC72C-40AC-4D7F-B2C0-D6B2777F0CAEQ38674466-CEEEBC28-B6A0-484A-93D1-F68ED9A6D257Q38805711-40D21B26-A2CF-477D-AD36-D62A794B38A3Q38839248-E556324C-DC52-4B7F-A8F5-7A41DFF7C860Q39044089-9C17E7F9-F195-45C0-B2B1-EB29E73342E7Q39091657-2329B6E1-8A9C-4C38-87AD-3EA791471289Q39384930-BBAB458D-0DD0-43E5-A71F-5BEBD14BEBB7Q39569177-9F112E5A-7B6D-4483-90DE-C25761D00F84Q39842547-877E8C12-BD56-4FB2-B9CC-AB19CD9A8B62Q40295063-54247EB1-D3DC-45FF-9A0F-BDF2AF533046Q40806353-2FF64814-E872-43D8-A3A9-B6777C91C199Q40990548-20DCEA35-5CEB-4119-B94D-F1FC4FF76C53Q41495990-E8FB64A6-D463-4484-880C-396125E00101Q47147931-4A2E40F7-7491-459A-947E-FC3F58E37BEEQ47443910-E09762DA-A0D4-47F9-993A-D945EEB3848EQ47574733-8DDBC486-FF4F-4BF5-9871-A6080D1DE9AAQ50015757-48C8EA5D-621F-4DF4-83AE-47F02CC3042FQ51454635-435F4065-917D-456B-B662-CE21E93AD00CQ53823061-2448AC99-46F2-4FE9-93F2-0F517ADD3CC6
P2860
The Clinical Spectrum ofDe NovoDonor-Specific Antibodies in Pediatric Renal Transplant Recipients
description
im August 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 28 August 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2014
@uk
name
The Clinical Spectrum ofDe Nov ...... ic Renal Transplant Recipients
@en
The Clinical Spectrum ofDe Nov ...... ic Renal Transplant Recipients
@nl
type
label
The Clinical Spectrum ofDe Nov ...... ic Renal Transplant Recipients
@en
The Clinical Spectrum ofDe Nov ...... ic Renal Transplant Recipients
@nl
prefLabel
The Clinical Spectrum ofDe Nov ...... ic Renal Transplant Recipients
@en
The Clinical Spectrum ofDe Nov ...... ic Renal Transplant Recipients
@nl
P2093
P2860
P356
P1476
The clinical spectrum of de no ...... ic renal transplant recipients
@en
P2093
P Wittenhagen
R Balasubramanian
P2860
P304
P356
10.1111/AJT.12859
P407
P577
2014-08-28T00:00:00Z